ARCHIVES

In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election

This article is from The Cancer Letter archive.

Vol. 06 No. 38 | September 26, 1980

Download PDF Visit The Full Archive

Related Articles

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

April 28, 2006

NCI To Proceed With Guidelines Unless Board Strongly Disagree

May 9, 1980

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008